US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell… EP News Bureau Jun 28, 2022 In the pivotal phase-III Transform trial, single infusion of Breyanzi significantly outperformed the nearly 30-year standard of…
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health… EP News Bureau Jan 18, 2021 The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias
